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Purification of the origin recognition complex (ORC) from wild-type budding yeast cells
more than two decades ago opened up doors to analyze the initiation of eukaryotic
chromosomal DNA replication biochemically. Although revised methods to purify ORC
from overproducing cells were reported later, purification of mutant proteins using these
systems still depends on time-consuming processes including genetic manipulation
to construct and amplify mutant baculoviruses or yeast strains as well as several
canonical protein fractionations. Here, we present a streamlined method to construct
mutant overproducers, followed by purification of mutant ORCs. Use of mammalian
cells co-transfected with conveniently mutagenized plasmids bearing a His tag excludes
many of the construction and fractionation steps. Transfection is highly efficient. All the six
subunits of ORC are overexpressed at a considerable level and isolated as a functional
heterohexameric complex. Furthermore, use of mammalian cells prevents contamination
of wild-type ORC from yeast cells. The method is applicable to wild-type and at least
three mutant ORCs, and the resultant purified complexes show expected biochemical
activities. The rapid acquisition of mutant ORCs using this system will boost systematic
biochemical dissection of ORC and can be even applied to the purification of protein
complexes other than ORC.
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INTRODUCTION
Purification of mutant proteins from overproducing cells constituted a milestone in biochemistry
to analyze proteins of interest. However, construction of mutant overproducers and purification of
the mutant proteins from these overproducers under native conditions depend on time-consuming
processes, especially when the activities of high-order protein complexes are to be examined in
vitro.
The origin recognition complex (ORC), consisting of Orc1/2/3/4/5/6, is one such protein
complex (Duncker et al., 2009; Kawakami and Katayama, 2010; Li and Stillman, 2012). ORC binds
to eukaryotic chromosomal replication origins in an ATP-dependent manner to recruit Cdc6,
Cdt1, and the MCM2-7 helicase core onto double-stranded DNA (Boos et al., 2012; Bell and
Kaguni, 2013; Yardimci andWalter, 2014; Tognetti et al., 2015). In the budding yeast Saccharomyces
cerevisiae, replication origins are called autonomously replicating sequences (ARSs). ARSs bear two
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major functional elements, namely, the essential A element
containing the ARS consensus sequence and the stimulatory B
elements (Figure 1). The A and B1 elements are essential for ORC
binding. All ORC subunits except for Orc6 are highly conserved
among eukaryotes and belong to the AAA+ (ATPases associated
with a variety of cellular activities) superfamily, although only
Orc1 and Orc5 bind to ATP. ORC ATPase activity is repressed
by ARS DNA in vitro and thought to ensure timely recruitment
of the MCM2-7 helicase. Orc1/2/3/4/5 also bear one or two
winged-helix DNA-binding motifs at the C-terminus. Orc1 bears
an extension at the N-terminus called the BAH (bromo-adjacent
homology) domain that binds to transcription-related proteins.
The linker region between BAH and AAA+ bears a highly
conserved, basic residue-rich motif called the eukaryotic origin
sensor (EOS) that solely and directly scans the essential element
FIGURE 1 | Cartoons summarizing ORC-ARS binding. (A) The
ORC-binding regions of ARS. The A and B1 elements and the ARS consensus
sequence are indicated. (B) Direct recognition of the A element by EOS with a
low affinity. Orc1 and Orc2/3/4/5 are shown in pink and white, respectively.
Orc6 and the WH domains of Orc2/3/4/5 are omitted for clarity. (C)
Recognition of the A element via EOS and other domains in a mutually
supportive manner with a higher affinity. The initial interaction of EOS with the
A element leads to additional interactions with other domains (possibly AAA+
and WH domains), resulting in high-affinity binding. The ORC subunits are
shown as in panel (B).
in ARS with a low affinity to achieve high-affinity binding of
the ORC hexamer to ARS (Figure 1; Kawakami et al., 2015).
Elimination of one subunit (except for Orc6) from the ORC
hexamer abolishes high-affinity binding of ORC to ARS (Lee
and Bell, 1997), suggesting that purification of the entire ORC
complex rather than individual subunits is important to analyze
the biological functions of ORC.
Purification of ORC was first achieved from wild-type
yeast cells (Bell and Stillman, 1992) and later revised using
overproducing cells. One approach is to use insect cells co-
transfected with three types of baculoviruses carrying two of
the six ORC subunits (Bell et al., 1995; Fujita et al., 1998; Sun
et al., 2012, 2013; Samel et al., 2014). Another approach is
to construct a yeast strain with inducible promoters (Remus
et al., 2009; Hizume et al., 2013). Although both approaches
can be used to analyze wild-type ORC, site-directed mutagenesis
of ORC is time-consuming with the aforementioned systems
because the former requires construction and amplification of
baculoviruses and the latter requires yeast genetics for integration
of the overproducing cassettes into the yeast genome. Both
approaches require several classical fractionation processes,
which are rate-limiting, to purify several mutant ORCs. In the
latter system, endogenous wild-type ORC might contaminate
the mutant ORC fractions, which would falsely indicate that the
mutants have hypomorphic phenotypes. Recently, an improved
method was developed to overcome part of these problems
in purification of ORC containing a site-specifically mutated
Orc4 subunit (Frigola et al., 2013; Coster et al., 2014). In
this method, CBP (calmodulin-binding peptide)-tagged Orc1,
mutant Orc4, and intact Orc2/3/5/6 were co-expressed in a
yeast strain in which endogenous wild-type Orc4 is Flag-
tagged. Affinity chromatography via the CBP-tagged Orc1 co-
purifies both wild-type and mutant Orc4; the contaminated
wild type is then excluded by immunodepletion during further
purification including HPLC-based fractionation steps. Although
this approach may be applicable to purification of ORC hexamers
containing any of the other mutant subunits, extra tagging(s)
to endogenous ORC loci for immunodepletion, as well as the
above-mentioned iterated gene integrations and still laborious
purification steps, should be required to obtain each of mutant
ORCs desired. Indeed, mutant ORC hexamers purified to date
are limited to those with point mutations in the representative
AAA+ domains (Klemm et al., 1997; Klemm and Bell, 2001;
Bowers et al., 2004; Speck et al., 2005; Speck and Stillman, 2007;
Coster et al., 2014) and deletion of the Orc1 BAH (Frigola et al.,
2013; Hizume et al., 2013).
The novel method described herein uses co-transfection
of mammalian cells with conveniently mutagenized plasmids
bearing a His tag (shorter than a CBP tag), which excludes
many of the construction and fractionation steps. HPLC-based
procedure in this method is kept minimum. Furthermore, use
of mammalian cells prevents contamination of wild-type ORC
from yeast cells, which eliminates immunodepletion step(s) of
wild type mentioned above. Purified wild-type and mutant
ORCs using this system showed expected biochemical activities;
therefore, the rapid acquisition of mutant ORCs using this highly
versatile system will boost systematic biochemical dissection of
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ORC and can be even applied to purify protein complexes other
than ORC.
MATERIALS AND METHODS
Buffers
Buffer H′ contained 50mM Hepes-KOH (pH 7.6), 0.02% NP-40,
10% [v/v] glycerol, 1mM benzamidine, 2.5 µg/ml pepstatin A,
0.1 mg/ml bacitracin, and 0.5mM PMSF. Lysis buffer was the
same as buffer H′ except that 0.3% NP-40, 400mMKCl, 5mM β-
mercaptoethanol, and 17.5mM imidazole were included. Wash
buffer was the same as lysis buffer except that 0.02% NP-40
was added. Elution buffer was the same as wash buffer except
that 500mM imidazole was added. H/0.2 and H/0.4 were the
same as buffer H′ except that 200 and 400 mM KCl were
added, respectively, as well as 1mM each of EDTA, EGTA, and
DTT. Buffer K contained 45mM Hepes-KOH [pH 7.6], 4.5mM
magnesium acetate, 140mM KCl, and 9% [v/v] glycerol.
Plasmids
The mammalian overexpression vector version (ver.) 3–5 (Uno
et al., 2012) was a gift from Dr. Hisao Masai. pHK106 (ORC1),
pHK107 (ORC2), pHK108 (ORC3), pHK109 (ORC4), pHK110
(ORC5), and pHK111 (ORC6) were constructed by sequence-
and ligation-independent cloning (SLIC; Li and Elledge, 2007) so
that PCR-amplified ORC1/2/3/4/5/6 fragments could be inserted
between the Kozak sequence and the HpaI site of ver. 3–5 and
that theHis andHA tags of ver. 3–5 were eliminated. pHK118was
constructed by QuikChange site-directed mutagenesis (Agilent)
using pHK106 so that a hexahistidine tag could be appended
to the C-terminus of Orc1 with a linker (WNLYFQS; identical
to a TEV recognition sequence). pHK122 was constructed by
Gibson assembly (Gibson et al., 2009) using pHK118 and
pACYCDuet-1 (Novagen) so that the p15Aori-cat cassette could
replace the ColE1ori-bla cassette of pHK118. pHK123 (orc1
K362A-His) and pHK124 (orc1 R367A-His) were constructed
by QuikChange mutagenesis using pHK118. pKSEO212 is a
plasmid for expression of mAG-6His-tagged hRad9. The hRad9
cDNA fragment was inserted into BamHI-XbaI sites of CSII-EF-
MCS-mAG-6His-Claspin-3Flag plasmid (Uno and Masai, 2011),
replacing the Claspin-3Flag with hRad9. The cloned genes and
flanking regions of the abovementioned plasmids were verified
by sequencing.
Overexpression of ORC Subunits
Overexpression in 293T cells was performed by transfection
using the PEI method as described previously (Uno et al.,
2012) except that 0.26 µg of each plasmid per 10 cm plate was
transfected, unless specified otherwise.
Western Blotting
Monoclonal antibodies against Orc1 (SB13) and His tag were
gifts from Dr. Bruce Stillman. Chemiluminescent signals were
detected in an ImageQuant LAS 4010 imager (GE Healthcare).
Quantitative Biochemistry
An electrophoretic mobility shift assay using Cy5-labeled ARS1
DNA was performed as described previously (Kawakami et al.,
2015). ORC ATPase activity, which is repressible by ARS, was
assayed as described previously (Klemm et al., 1997) with slight
modifications. Briefly, a 76-bp segment of wild-type ARS1
(position 818–893) or a mutant (–ACS) was amplified by PCR
using primers HK301 (CTTGCCTGCAGGCCTTTTG) and
HK302 (ATCTTTACATCTTGTTATTTTACAGATTTTATG).
The amplified DNA was incubated with 0.4 pmol of ORC, 15
µM [α-32P]ATP, and 3 pmol of a 290-bp GC-rich competitor
(Speck et al., 2005) for 45min at 25◦C in 10 µl of buffer K. The
reaction was stopped by adding 5 µl of 2% SDS. The resultant
radiolabeled ADP was quantified by thin layer chromatography,
followed by phosphoimaging as described previously (Kawakami
et al., 2005).
RESULTS AND DISCUSSION
Construction of S. cerevisiae
ORC-Overproducing Plasmids for a
Mammalian Expression System
To overproduce S. cerevisiae ORC in mammalian cells, we
modified the ver. 3–5 vector for transfection, which was originally
developed to overexpress proteins that are not overexpressed
well in bacterial or insect cells (Figure 2; Uno and Masai, 2011;
Uno et al., 2012). Ver. 3–5 is a shuttle vector carrying PEF−1α, a
Kozak sequence, a His tag, a multiple cloning site, and an HA
tag. Ver. 3–5 also bears an SV40 origin, which could help to
maintain the vector episomally in mammalian cells expressing
the large T antigen, such as 293T cells. To maintain the plasmid
in Escherichia coli, ver. 3–5 also bears bla and ColE1 ori. We
first cloned one of the ORC1/2/3/4/5/6 genes into ver. 3–5 so
that the N-terminal His tag and C-terminal HA tag of the vector
were eliminated, yielding pHK106 through to pHK111. By site-
directed mutagenesis, a hexahistidine sequence with a linker
was appended just before the stop codon of ORC1, yielding
pHK118. This tag, consisting of 13 amino acids, is shorter than
a CBP-TEV tag previously used for Orc1 tagging (Frigola et al.,
2013). Addition of a short tag, such as His12 or His-Strep II, to
the C-terminus of Orc1 does not affect Orc1 function in vivo
(Kawakami et al., 2015). We noticed that introduction of certain
orc1 mutations into pHK118 by site-directed mutagenesis was
unsuccessful. Because the same mutation could be introduced
into anotherORC1 plasmid under the control of the nativeORC1
promoter using the same mutagenic primers (Kawakami et al.,
2015), one plausible idea is that leaky expression of Orc1 from
pHK118 may be extremely toxic in E. coli cells only when a
certain orc1 mutation is introduced. Because Orc1 solely binds
to the ARS sequence via a domain termed EOS (Kawakami et al.,
2015), similar binding to a similar sequence in the E. coli genome
may be affected by the mutation and interfere with a certain
cellular process in vivo. Alternatively, adverse interactions of the
Orc1 AAA+ domain with other AAA+ proteins in E. coli could
be stimulated in certain orc1mutants.
To reduce the total leaky expression level, the plasmid
replication origin along with the selectable marker was replaced
so that the plasmid copy number in E. coli could be reduced.
The resultant plasmid pHK122 bears a p15A ori with the
cat gene and the mutant plasmids pHK123 and pHK124
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FIGURE 2 | Construction of ORC-overproducing plasmids. All the pHK plasmids used in this study are derivatives of ver. 3–5. See text for details.
were successfully constructed, supporting the aforementioned
hypothesis regarding the risk of toxicity using pHK118.
Overexpression of ORC Subunits by
Convenient Co-Transfection
To test if Orc1 is overexpressed in 293T cells using the
constructed plasmid, a series of transient co-expression
experiments were performed. A control experiment using a
plasmid expressing mAG-tagged hRad9 indicated that most
cells were successfully transfected (Figure 3A). Under this
condition, expression of His-tagged Orc1 co-transfected with
Orc6 was confirmed by Western blotting (Figure 3B). When
intact Orc2/3/4/5/6 plasmids were co-transfected with His-
tagged Orc1 plasmid, expression of His-tagged Orc1 was also
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FIGURE 3 | Co-overexpression of Orc1 and other ORC subunit(s). (A) Estimation of the transfection efficiency. 293T cells were transfected with a plasmid
bearing mAG-tagged hRad9 and incubated for 48 h. Microscopic observation was performed, and phase-contrast and fluorescence images are shown. (B) 293T
cells were co-transfected with the indicated ORC plasmids and incubated for 48 h. Whole cells were lyzed and analyzed by 9% SDS-PAGE, followed by Western
blotting using an anti-Orc1 antibody. Ponceau staining was also performed as a loading control. (C) Isolation of ORC and Orc1–5 by pulldown. Orc1-His, Orc2, Orc3,
Orc4, and Orc5 with (+) or without (–) Orc6 were co-overexpressed. Cleared lysates (input; INP) were subjected to a pulldown assay (PD) and analyzed by 9%
SDS-PAGE, followed by Coomassie staining. All lanes originate from the same gel.
detected at a level similar to that observed when only His-tagged
Orc1 plasmid was transfected. Degradation of Orc1 was not
observed. Orc1-His and five major proteins corresponding to
Orc2/3/4/5/6 were co-pulled down (Figure 3C), suggesting that
all of the ORC subunits were co-overexpressed and formed a
complex. Although Uno et al. successfully co-transfected up
to three plasmids simultaneously (Uno and Masai, 2011; Uno
et al., 2012), our data demonstrated that co-transfection of six
plasmids was tolerable for co-overexpression using this system.
Hereafter, 0.26 µg of each plasmid per 10-cm plate was used
during the course of this study.
Purification of ORC Lacking the Orc6
Subunit (Orc1–5)
To minimize and simplify the column chromatography steps
during purification, we first established a purification method of
Orc1–5, which takes only 2 days (Figure 4). Orc1/2/3/4/5 form
a stable heteropentamer (Lee and Bell, 1997; Chen et al., 2008).
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FIGURE 4 | Workflow of overexpression and purification of mutant ORCs using a mammalian expression system. See text for details.
The method to purify Orc1–5 from cells using 40 15-cm plates is
detailed below.
1. Resuspend the cells in 50ml of lysis buffer.
2. Add 4500 units of TurboNuclease (Accelagen) and incubate
for 30min.
3. Centrifuge at 15,000× g for 20min.
4. Transfer the supernatant to 2.5ml bed volume of MagneHis
beads (Promega), prewashed with 50ml of water, and mix
gently for 1 h on a rotation wheel.
5. Wash the magnetic beads five times with 50ml of wash buffer.
6. Elute the beads four times with 1.7–2.5ml of elution buffer.
7. Concentrate the peak fractions on a mini SP Sepharose
column, followed by a step elution with buffer H/0.4.
8. Load the peak fractions onto a Superdex 200 column
equilibrated with buffer H/0.2.
9. Concentrate the peak fractions using another mini SP
Sepharose column, divide into aliquots, and snap-freeze in
liquid nitrogen.
Proteins at each step were monitored by SDS-PAGE (Figure 5).
Most cellular proteins were soluble (lanes 1 and 2). Enrichment
of a band at ∼110 kDa was observed after MagneHis pulldown,
corresponding to Orc1-His (106 kDa; lane 5). Some proteins
including Orc2/3/4/5 were also enriched (lane 5). Orc1-His and
Orc2/3/4/5 were concentrated by SP Sepharose (lane 7 and
Table 1A). These proteins co-migrated during gel filtration (lanes
9–14), suggesting that they form a complex. The resultant ORC
complex was purified to almost homogeneity. Concentration of
the peak fractions yielded ∼0.7mg of protein, which is sufficient
for most biochemical applications (Table 1).
Purification of the ORC Hexamer
Containing Orc1 K362A
We next attempted to purify mutant ORC hexamers. This time,
we purified ORC containing His-tagged Orc1 K362A from cells
using 20 15-cm plates, half the number that was used for Orc1–
5. This time we substituted HisTrap column chromatography
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FIGURE 5 | Purification of Orc1–5. 293T cells co-overexpressing Orc1-His,
Orc2, Orc3, Orc4, and Orc5 were lyzed and fractionated. The indicated
volume was taken and analyzed using 9% SDS-PAGE, followed by Coomassie
staining. The migration of each ORC subunit is indicated. W, whole cells; INP,
input; FT, flow-through; W5, the fifth wash fraction; E, eluate; and 14–21,
fraction numbers.
TABLE 1 | Purification tables of mutant ORCs.
Fraction Step Volume Concentration Protein Yield
(ml) (mg/ml) (mg) (%)
(A) ORC
I. Lysate 12 28 340a [100]
II. HisTrap 10 0.84 8.4 2.5
III. SP Sepharose (first) 1.0 2.6 2.6 0.76
IV. Superdex 200 6.0 N.D. N/A N/A
V. SP Sepharose (second) 0.65 1.1 0.72 0.21
(B) Orc1–5
I. Lysate 50 N.D. N/Ab
II. MagneHis 9.0 1.8 16 [100]
III. SP Sepharose (first) 1.0 6.5 6.5 41
IV. Superdex 200 6.0 0.73 4.4 28
V. SP Sepharose (second) 0.50 4.6 2.3 14
(C) ORC containing Orc1 K362A
I. Lysate 9.5 10 97c [100]
II. HisTrap 9.0 0.39 3.5 3.6
III. SP Sepharose (first) 1.0 1.2 1.2 1.2
IV. Superdex 200 6.0 0.12 0.73 0.75
V. SP Sepharose (second) 0.38 1.1 0.40 0.41
(D) ORC containing Orc1 R367A
I. Lysate 10 16 156d [100]
II. HisTrap 9.0 0.61 5.5 3.5
III. SP Sepharose (first) 1.0 2.1 2.1 1.3
IV. Superdex 200 6.0 0.19 1.2 0.77
V. SP Sepharose (second) 0.75 1.0 0.74 0.47
aFrom ∼2.4ml of wet cells (20 15-cm plates).
bFrom 4ml of wet cells (40 15-cm plates).
cFrom ∼1ml of wet cells (20 15-cm plates).
dFrom ∼1.7ml of wet cells (20 15-cm plates).
FIGURE 6 | Purification of ORC containing Orc1 K362A. 293T cells
co-overexpressing Orc1 K362A-His, Orc2, Orc3, Orc4, Orc5, and Orc6 were
lyzed and fractionated using HisTrap (A) and SP Sepharose and Superdex 200
columns (B). The indicated volume was taken and analyzed using 9%
SDS-PAGE, followed by Coomassie staining. The migration of each ORC
subunit is indicated.
for MagneHis (Figure 4) to perform a linear gradient elution.
The revised method takes only 1 week, including the DNA
work such as site-directed mutagenesis. Orc1 K362A-His and
Orc1 R367A-His were overexpressed in 293T cells as soluble
proteins, similar to wild-type Orc1 (Supplementary Figure 1).
When HisTrap column chromatography was performed, Orc1
K362A-His was eluted relatively broadly, peaking at fraction
numbers 19–21 (Figure 6A). Somemajor proteins corresponding
to Orc2/3/4/5/6 co-migrated slightly slower, peaking at fraction
numbers 23 and 24 (Figure 6A), suggesting that His-tagged Orc1
K362A and His-tagged Orc1 K362A containing Orc2/3/4/5/6
eluted at slightly different imidazole concentrations. Fractions
containing all of the ORC subunits were pooled, concentrated,
and further fractionated by gel filtration. As expected, His-
tagged Orc1-K362A was separated into two fractions, the faster
co-migrated with Orc2/3/4/5/6 and the slower eluted alone
(Figure 6B). Each band was nearly stoichiometric, suggesting
that His-tagged Orc1 K362A as well as Orc2/3/4/5/6 formed a
stoichiometric hexamer. Similar results were obtained during
preparation of wild-type ORC and ORC containing His-tagged
Orc1 R367A; ∼0.4–0.7mg of purified ORC was yielded under
these conditions, which is sufficient for typical biochemical assays
(Table 1).
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FIGURE 7 | In vitro activities of mutant ORC proteins. (A) The
ARS-binding activity of Orc1–5 was examined by an electrophoretic mobility
shift assay using Cy5-labeled wild-type (WT) or mutant (A− B2− B3−) ARS1
DNA. (B–D) Repression of ORC ATPase activity by ARS1 DNA in an
EOS-dependent manner. WT or mutant (–ACS) ARS1 DNA was incubated with
WT ORC (B), ORC containing Orc1 K362A (C), or ORC containing Orc1
R367A (D), yielding ATPase rates in the absence of DNA of 0.33 (B), 0.28 (C),
and 0.25 (D) pmol/min/pmol ORC, respectively.
Evaluation of Biochemical Activities
To assess if the purified wild-type and mutant ORCs can be
used for downstream applications such as biochemical analyzes,
we first performed an electrophoretic mobility shift assay using
Orc1–5 and wild-type and mutant ARS1 DNA. ORC and Orc1–
5 bind to ARS at the nanomolar level in S. cerevisiae (Speck
et al., 2005; Chen et al., 2008). Indeed, an Orc1–5-dependent
band shift was seen at concentrations ≤2 nM with wild-type
ARS1, whereas such shifts were not observed with mutant ARS1
(Figure 7A).
Next, the effects of ARS1 DNA on ORC ATPase activity
were assessed using ORC containing Orc1 K362A or Orc1
R367A. ORC ATPase activity was repressed by double-
stranded DNA in a wild-type ARS sequence-dependent manner
(Figure 7B), consistent with a previous finding (Klemm et al.,
1997). By contrast, only partial or no significant repression
was observed using ORC containing Orc1 K362A and Orc1
R367A, respectively (Figures 7C,D), consistent with the in vivo
residual ARS-binding activity of Orc1 K362A and Orc1 R367A
(Kawakami et al., 2015). These results suggest that mutant ORCs
purified using the method reported herein can be used for
biochemical applications.
Versatility of the Devised System
In this study, we established a rapid method for the
overexpression and purification of mutant ORC hexamers.
Compared with previously published methods, the method
described in this paper is especially more suitable to purify ORC
mutants with multiple mutation sites or lethal effect. Many of the
commonly used eukaryotic shuttle vectors bear a ColE1 origin
that confers replication at high copy numbers on the shuttle
vectors in E. coli. Although this property is technically beneficial
to yield a large amount of DNA for downstream applications
such as cloning and transformation/transfection, it may also
cause toxicity in E. coli cells when a certain gene is cloned.
Replacement of the origin with a lower copy number replicon
may overcome such cloning problems in such circumstances.
Indeed, Wang and Mullins reported that certain lentivirus-
derived sequences can be cloned into a vector bearing a p15A
ori, but not into vectors bearing a ColE1 ori such as pBluescript
and pUC (Wang and Mullins, 1995). The combination of
293T cells with the modified expression vector reported in this
study will be a powerful tool for future protein overexpression
to perform further mutational analyzes of Orc1 and the
other ORC subunits, and even purification of proteins other
than ORC.
AUTHOR CONTRIBUTIONS
All the authors conceived and designed the research. HK
and TK designed the experiments. HK and EO performed
the experiments. HK, EO, and TK analyzed the data. HK
and TK wrote the manuscript with critical input from EO
and TT.
FUNDING
This work was supported by MEXT/JSPS KAKENHI
(24870021, 15K18504, 25131714, 25440011, 26114714,
and 26291004), the Takeda Science Foundation, the Naito
Foundation, the NIG Collaborative Research Program (2011-
B1, 2012-B12, and 2013-B1), and the Kyushu University
Interdisciplinary Programs in Education and Projects in Research
Development.
Frontiers in Microbiology | www.frontiersin.org 8 April 2016 | Volume 7 | Article 521
Kawakami et al. Rapid Mutant ORC Preparation
ACKNOWLEDGMENTS
We thank Dr. Bruce Stillman for antibodies, Dr. Hisao Masai for
a plasmid, and the Kyushu University Research Support Center
for shared resources.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.00521
REFERENCES
Bell, S. P., and Kaguni, J. M. (2013). Helicase loading at chromosomal
origins of replication. Cold Spring Harb. Perspect. Biol. 5:a010124. doi:
10.1101/cshperspect.a010124
Bell, S. P., Mitchell, J., Leber, J., Kobayashi, R., and Stillman, B. (1995). The
multidomain structure of Orc1p reveals similarity to regulators of DNA
replication and transcriptional silencing. Cell 83, 563–568. doi: 10.1016/0092-
8674(95)90096-9
Bell, S. P., and Stillman, B. (1992). ATP-dependent recognition of eukaryotic
origins of DNA replication by a multiprotein complex. Nature 357, 128–134.
doi: 10.1038/357128a0
Boos, D., Frigola, J., and Diﬄey, J. F. X. (2012). Activation of the replicative DNA
helicase: breaking up is hard to do. Curr. Opin. Cell Biol. 24, 423–430. doi:
10.1016/j.ceb.2012.01.011
Bowers, J. L., Randell, J. C. W., Chen, S., and Bell, S. P. (2004). ATP hydrolysis by
ORC catalyzes reiterative Mcm2-7 assembly at a defined origin of replication.
Mol. Cell 16, 967–978. doi: 10.1016/j.molcel.2004.11.038
Chen, Z., Speck, C., Wendel, P., Tang, C., Stillman, B., and Li, H. (2008).
The architecture of the DNA replication origin recognition complex in
Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 105, 10326–10331. doi:
10.1073/pnas.0803829105
Coster, G., Frigola, J., Beuron, F., Morris, E. P., and Diﬄey, J. F. X. (2014). Origin
licensing requires ATP binding and hydrolysis by theMCM replicative helicase.
Mol. Cell 55, 666–677. doi: 10.1016/j.molcel.2014.06.034
Duncker, B. P., Chesnokov, I. N., and McConkey, B. J. (2009). The origin
recognition complex protein family. Genome Biol. 10:214. doi: 10.1186/gb-
2009-10-3-214
Frigola, J., Remus, D., Mehanna, A., and Diﬄey, J. F. X. (2013). ATPase-dependent
quality control of DNA replication origin licensing. Nature 495, 339–343. doi:
10.1038/nature11920
Fujita, M., Hori, Y., Shirahige, K., Tsurimoto, T., Yoshikawa, H., and Obuse, C.
(1998). Cell cycle dependent topological changes of chromosomal replication
origins in Saccharomyces cerevisiae.Genes Cells 3, 737–749. doi: 10.1046/j.1365-
2443.1998.00226.x
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., and Smith,
H. O. (2009). Enzymatic assembly of DNA molecules up to several hundred
kilobases. Nat. Methods 6, 343–345. doi: 10.1038/nmeth.1318
Hizume, K., Yagura, M., and Araki, H. (2013). Concerted interaction between
origin recognition complex (ORC), nucleosomes and replication origin
DNA ensures stable ORC-origin binding. Genes Cells 18, 764–779. doi:
10.1111/gtc.12073
Kawakami, H., and Katayama, T. (2010). DnaA, ORC, and Cdc6: similarity
beyond the domains of life and diversity. Biochem. Cell Biol. 88, 49–62. doi:
10.1139/O09-154
Kawakami, H., Keyamura, K., and Katayama, T. (2005). Formation of an ATP-
DnaA-specific initiation complex requires DnaA Arginine 285, a conserved
motif in the AAA+ protein family. J. Biol. Chem. 280, 27420–27430. doi:
10.1074/jbc.M502764200
Kawakami, H., Ohashi, E., Kanamoto, S., Tsurimoto, T., and Katayama, T. (2015).
Specific binding of eukaryotic ORC to DNA replication origins depends on
highly conserved basic residues. Sci. Rep. 5, 14929. doi: 10.1038/srep14929
Klemm, R. D., Austin, R. J., and Bell, S. P. (1997). Coordinate binding of ATP and
origin DNA regulates the ATPase activity of the origin recognition complex.
Cell 88, 493–502. doi: 10.1016/S0092-8674(00)81889-9
Klemm, R. D., and Bell, S. P. (2001). ATP bound to the origin recognition complex
is important for preRC formation. Proc. Natl. Acad. Sci. U.S.A. 98, 8361–8367.
doi: 10.1073/pnas.131006898
Lee, D. G., and Bell, S. P. (1997). Architecture of the yeast origin recognition
complex bound to origins of DNA replication. Mol. Cell. Biol. 17, 7159–7168.
doi: 10.1128/MCB.17.12.7159
Li, H., and Stillman, B. (2012). The origin recognition complex: a biochemical and
structural view. Subcell. Biochem. 62, 37–58. doi: 10.1007/978-94-007-4572-8_3
Li, M. Z., and Elledge, S. J. (2007). Harnessing homologous recombination in
vitro to generate recombinant DNA via SLIC. Nat. Methods 4, 251–256. doi:
10.1038/nmeth1010
Remus, D., Beuron, F., Tolun, G., Griffith, J. D., Morris, E. P., and Diﬄey,
J. F. X. (2009). Concerted loading of Mcm2-7 double hexamers around
DNA during DNA replication origin licensing. Cell 139, 719–730. doi:
10.1016/j.cell.2009.10.015
Samel, S. A., Fernández-Cid, A., Sun, J., Riera, A., Tognetti, S., Herrera, M. C.,
et al. (2014). A unique DNA entry gate serves for regulated loading of the
eukaryotic replicative helicase MCM2-7 onto DNA. Genes Dev. 28, 1653–1666.
doi: 10.1101/gad.242404.114
Speck, C., Chen, Z., Li, H., and Stillman, B. (2005). ATPase-dependent cooperative
binding of ORC and Cdc6 to origin DNA. Nat. Struct. Mol. Biol. 12, 965–971.
doi: 10.1038/nsmb1002
Speck, C., and Stillman, B. (2007). Cdc6 ATPase activity regulates ORC · Cdc6
stability and the selection of specific DNA sequences as origins of DNA
replication. J. Biol. Chem. 282, 11705–11714. doi: 10.1074/jbc.M700399200
Sun, J., Evrin, C., Samel, S. A., Fernández-Cid, A., Riera, A., Kawakami, H., et al.
(2013). Cryo-EM structure of a helicase loading intermediate containing ORC-
Cdc6-Cdt1-MCM2-7 bound to DNA. Nat. Struct. Mol. Biol. 20, 944–951. doi:
10.1038/nsmb.2629
Sun, J., Kawakami, H., Zech, J., Speck, C., Stillman, B., and Li, H. (2012). Cdc6-
induced conformational changes in ORC bound to origin DNA revealed by
cryo-electron microscopy. Structure 20, 534–544. doi: 10.1016/j.str.2012.01.011
Tognetti, S., Riera, A., and Speck, C. (2015). Switch on the engine: how the
eukaryotic replicative helicase MCM2-7 becomes activated. Chromosoma 124,
13–26. doi: 10.1007/s00412-014-0489-2
Uno, S., and Masai, H. (2011). Efficient expression and purification of human
replication fork-stabilizing factor, Claspin, from mammalian cells: DNA-
binding activity and novel protein interactions. Genes Cells 16, 842–856. doi:
10.1111/j.1365-2443.2011.01535.x
Uno, S., You, Z., and Masai, H. (2012). Purification of replication factors using
insect and mammalian cell expression systems. Methods 57, 214–221. doi:
10.1016/j.ymeth.2012.06.016
Wang, R. F., and Mullins, J. I. (1995). Mammalian cell/vaccinia virus expression
vectors with increased stability of retroviral sequences in Escherichia coli:
production of feline immunodeficiency virus envelope protein. Gene 153,
197–202. doi: 10.1016/0378-1119(94)00743-C
Yardimci, H., and Walter, J. C. (2014). Prereplication-complex formation:
a molecular double take? Nat. Struct. Mol. Biol. 21, 20–25. doi:
10.1038/nsmb.2738
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Kawakami, Ohashi, Tsurimoto and Katayama. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Microbiology | www.frontiersin.org 9 April 2016 | Volume 7 | Article 521
